Nuclear Medicine and Biology
Volume 33, Issue 5 , Pages 625-634, July 2006

Pyrazolyl conjugates of bombesin: a new tridentate ligand framework for the stabilization of fac-[M(CO)3]+ moiety

  • Susana Alves

      Affiliations

    • Departamento de Química, Instituto Tecnológico e Nuclear, 2686-953 Sacavém, Portugal
  • ,
  • Joao D.G. Correia

      Affiliations

    • Departamento de Química, Instituto Tecnológico e Nuclear, 2686-953 Sacavém, Portugal
  • ,
  • Isabel Santos

      Affiliations

    • Departamento de Química, Instituto Tecnológico e Nuclear, 2686-953 Sacavém, Portugal
  • ,
  • Bhadrasetty Veerendra

      Affiliations

    • Department of Radiology, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
  • ,
  • Gary L. Sieckman

      Affiliations

    • Research Division, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
  • ,
  • Timothy J. Hoffman

      Affiliations

    • Research Division, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
    • The Radiopharmaceutical Sciences Institute, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
  • ,
  • Tammy L. Rold

      Affiliations

    • Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
  • ,
  • Said Daibes Figueroa

      Affiliations

    • The Radiopharmaceutical Sciences Institute, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
  • ,
  • Lauren Retzloff

      Affiliations

    • Department of Radiology, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
  • ,
  • Joseph McCrate

      Affiliations

    • Department of Radiology, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
  • ,
  • Adam Prasanphanich

      Affiliations

    • Department of Radiology, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
  • ,
  • Charles J. Smith

      Affiliations

    • Department of Radiology, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
    • University of Missouri Research Reactor Center, University of Missouri-Columbia, Columbia, MO 65211, USA
    • Research Division, Harry S. Truman Memorial Veterans' Hospital, Columbia, MO 65201, USA
    • Department of Internal Medicine, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
    • The Radiopharmaceutical Sciences Institute, University of Missouri-Columbia School of Medicine, Columbia, MO 65211, USA
    • Corresponding Author InformationCorresponding author. Harry S. Truman Memorial VA Hospital, Research Service Room A005, 800 Hospital Drive, Columbia, MO 65201, USA. Tel.: +1 573 814 6000x3683; fax: +1 573 882 1663.

Received 1 November 2005; received in revised form 28 February 2006; accepted 17 March 2006. published online 02 May 2006.

Abstract 

We have described the synthesis of tridentate pyrazolyl ligand frameworks for coordination to the fac-[*M(CO)3]+ metal fragment (*M=186/188Re or 99mTc). These ligands impart a degree of kinetic inertness on the metal center, warranting their study in biological systems. We herein report in vitro/in vivo radiolabeling investigations of a new series of pyrazolyl bombesin (BBN) conjugates radiolabeled via the Isolink kit. These new conjugates are based on the general structure [99mTc-pyrazolyl-X-BBN[7–14]NH2], where X=β-alanine, serylserylserine or glycylglycylglycine. The pyrazolyl ligand is a tridentate ligand framework that coordinates the metal center through nitrogen donor atoms. The results of these investigations demonstrate the ability of these new conjugates to specifically target the gastrin-releasing peptide receptor subtype 2, which is overexpressed on human prostate PC-3 cancerous tissues. Therefore, these studies suggest the tridentate pyrazolyl ligand framework to be an ideal candidate for the design and development of low-valent 99mTc-based diagnostic radiopharmaceuticals based on BBN or other targeting vectors.

Keywords: Technetium, Carbonyl, Bombesin, Conjugates

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(06)00064-3

doi:10.1016/j.nucmedbio.2006.03.007

Nuclear Medicine and Biology
Volume 33, Issue 5 , Pages 625-634, July 2006